Free tool
FAERS Monitor: Prilosec
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 022056 or its brand name (Prilosec, Omeprazole Magnesium). Reports on generic versions are filed under their own applications.
Reports
107,223
Serious
75,635
71% of reports
Hospitalization
24,866
Death reported
9,190
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- chronic kidney disease29,730
- acute kidney injury15,183
- renal failure12,470
- end stage renal disease8,730
- renal injury8,229
- nausea6,242
- drug ineffective5,971
- pain5,718
- fatigue5,633
- diarrhoea4,967
- gastrooesophageal reflux disease4,670
- dyspnoea4,134
- headache3,976
- death3,787
- vomiting3,496
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1,427 |
| 2005 | 1,417 |
| 2006 | 1,783 |
| 2007 | 1,511 |
| 2008 | 1,889 |
| 2009 | 2,696 |
| 2010 | 3,462 |
| 2011 | 4,210 |
| 2012 | 5,934 |
| 2013 | 3,772 |
| 2014 | 4,254 |
| 2015 | 6,756 |
| 2016 | 6,721 |
| 2017 | 5,535 |
| 2018 | 18,057 |
| 2019 | 17,650 |
| 2020 | 6,369 |
| 2021 | 4,941 |
| 2022 | 2,950 |
| 2023 | 1,899 |
| 2024 | 1,569 |
| 2025 | 1,395 |
| 2026 | 1,017 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,946,936 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| end stage renal diseaseSignal | 8,730 | 179.0 | 174.0 | 807,035 |
| chronic kidney diseaseSignal | 29,730 | 125.4 | 123.7 | 2,242,220 |
| renal injurySignal | 8,229 | 74.7 | 72.9 | 433,526 |
| acute kidney injurySignal | 15,183 | 21.5 | 21.2 | 269,204 |
| renal failureSignal | 12,470 | 20.2 | 19.9 | 207,782 |
| gastrooesophageal reflux diseaseSignal | 4,670 | 12.0 | 11.7 | 44,598 |
| pain | 5,718 | 1.8 | 1.8 | 2,211 |
| nausea | 6,242 | 1.6 | 1.5 | 1,261 |
| diarrhoea | 4,967 | 1.5 | 1.5 | 885 |
| vomiting | 3,496 | 1.5 | 1.4 | 518 |
| dyspnoea | 4,134 | 1.4 | 1.4 | 557 |
| fatigue | 5,633 | 1.4 | 1.4 | 728 |
| headache | 3,976 | 1.2 | 1.2 | 197 |
| drug ineffective | 5,971 | 0.9 | 0.9 | 89 |
| death | 3,787 | 0.9 | 0.8 | 87 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.